These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 30861334

  • 1. Efficacy and safety of add-on tacrolimus versus leflunomide in rheumatoid arthritis patients with inadequate response to methotrexate.
    Shin K, Baek HJ, Kang YM, Cha HS, Kang SW, Park SH, Jun JB, Lee YJ, Choi IA, Song YW.
    Int J Rheum Dis; 2019 Jun; 22(6):1115-1122. PubMed ID: 30861334
    [Abstract] [Full Text] [Related]

  • 2. Comparing methotrexate monotherapy with methotrexate plus leflunomide combination therapy in psoriatic arthritis: protocol of a randomized, placebo-controlled, double-blind clinical trial (COMPLETE-PsA).
    Mulder MLM, Vriezekolk JE, den Broeder N, Mahler EAM, Helliwell PS, van den Hoogen FHJ, den Broeder AA, Wenink MH.
    Trials; 2020 Feb 10; 21(1):155. PubMed ID: 32041657
    [Abstract] [Full Text] [Related]

  • 3. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
    Cohen S, Cannon GW, Schiff M, Weaver A, Fox R, Olsen N, Furst D, Sharp J, Moreland L, Caldwell J, Kaine J, Strand V.
    Arthritis Rheum; 2001 Sep 10; 44(9):1984-92. PubMed ID: 11592358
    [Abstract] [Full Text] [Related]

  • 4. Anti-arthritic effect of β-caryophyllene and its ameliorative role on methotrexate and/or leflunomide-induced side effects in arthritic rats.
    El-Sheikh SMA, Abd El-Alim AEF, Galal AAA, El-Sayed RG, El-Naseery NI.
    Life Sci; 2019 Sep 15; 233():116750. PubMed ID: 31408659
    [Abstract] [Full Text] [Related]

  • 5. Combination leflunomide and methotrexate (MTX) therapy for patients with active rheumatoid arthritis failing MTX monotherapy: open-label extension of a randomized, double-blind, placebo controlled trial.
    Kremer J, Genovese M, Cannon GW, Caldwell J, Cush J, Furst DE, Luggen M, Keystone E, Bathon J, Kavanaugh A, Ruderman E, Coleman P, Curtis D, Kopp E, Kantor S, Weisman M, Waltuck J, Lindsley HB, Markenson J, Crawford B, Fernando I, Simpson K, Strand V.
    J Rheumatol; 2004 Aug 15; 31(8):1521-31. PubMed ID: 15290730
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of low-dose tacrolimus for active rheumatoid arthritis with an inadequate response to methotrexate.
    Lee WS, Lee SI, Lee MS, Kim SI, Lee SS, Yoo WH.
    Korean J Intern Med; 2016 Jul 15; 31(4):779-87. PubMed ID: 26961485
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of adjunct tacrolimus treatment in patients with rheumatoid arthritis with inadequate responses to methotrexate.
    Kitahama M, Nakajima A, Inoue E, Taniguchi A, Momohara S, Yamanaka H.
    Mod Rheumatol; 2013 Jul 15; 23(4):788-93. PubMed ID: 22975732
    [Abstract] [Full Text] [Related]

  • 8. Preliminary evaluation in rheumatoid arthritis activity in patients treated with TNF-alpha blocker plus methotrexate versus methotrexate or leflunomide alone.
    Wisłowska M, Jakubicz D.
    Rheumatol Int; 2007 May 15; 27(7):641-7. PubMed ID: 17235556
    [Abstract] [Full Text] [Related]

  • 9. Comparison of combination therapy with methotrexate and sinomenine or leflunomide for active rheumatoid arthritis: A randomized controlled clinical trial.
    Huang RY, Pan HD, Wu JQ, Zhou H, Li ZG, Qiu P, Zhou YY, Chen XM, Xie ZX, Xiao Y, Huang QC, Liu L.
    Phytomedicine; 2019 Apr 15; 57():403-410. PubMed ID: 30851515
    [Abstract] [Full Text] [Related]

  • 10. Elevated liver enzyme tests among patients with rheumatoid arthritis or psoriatic arthritis treated with methotrexate and/or leflunomide.
    Curtis JR, Beukelman T, Onofrei A, Cassell S, Greenberg JD, Kavanaugh A, Reed G, Strand V, Kremer JM.
    Ann Rheum Dis; 2010 Jan 15; 69(1):43-7. PubMed ID: 19147616
    [Abstract] [Full Text] [Related]

  • 11. Comparison of combination therapies in the treatment of rheumatoid arthritis: leflunomide-anti-TNF-alpha versus methotrexate-anti-TNF-alpha.
    De Stefano R, Frati E, Nargi F, Baldi C, Menza L, Hammoud M, Galeazzi M.
    Clin Rheumatol; 2010 May 15; 29(5):517-24. PubMed ID: 20082236
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of leflunomide or methotrexate plus subcutaneous tumour necrosis factor-alpha blocking agents in rheumatoid arthritis.
    Benucci M, Saviola G, Baiardi P, Manfredi M, Sarzi-Puttini P, Atzeni F.
    Int J Immunopathol Pharmacol; 2011 May 15; 24(1):269-74. PubMed ID: 21496415
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of additional use of tacrolimus in patients with early rheumatoid arthritis with inadequate response to DMARDs--a multicenter, double-blind, parallel-group trial.
    Kawai S, Takeuchi T, Yamamoto K, Tanaka Y, Miyasaka N.
    Mod Rheumatol; 2011 Oct 15; 21(5):458-68. PubMed ID: 21347803
    [Abstract] [Full Text] [Related]

  • 14. Effectiveness of maintenance therapy with methotrexate compared with leflunomide for patients with RA having achieved disease control with both these drugs: results of a predefined sub-analysis of CareRA, a pragmatic RCT.
    Stouten V, Michiels S, Westhovens R, De Cock D, Belba A, Pazmino S, Van der Elst K, Joly J, Verschueren P.
    Clin Rheumatol; 2020 Sep 15; 39(9):2593-2601. PubMed ID: 32166429
    [Abstract] [Full Text] [Related]

  • 15. Comparison of efficacy and safety of tacrolimus and methotrexate in combination with abatacept in patients with rheumatoid arthritis; a retrospective observational study in the TBC Registry.
    Fujibayashi T, Takahashi N, Kida D, Kaneko A, Hirano Y, Fukaya N, Yabe Y, Oguchi T, Tsuboi S, Miyake H, Takemoto T, Kawasaki M, Ishiguro N, Kojima T.
    Mod Rheumatol; 2015 Sep 15; 25(6):825-30. PubMed ID: 25775147
    [Abstract] [Full Text] [Related]

  • 16. Eight versus 16-week re-evaluation period in rheumatoid arthritis patients treated with leflunomide or methotrexate accompanied by moderate dose prednisone.
    Fiehn C, Jacki S, Heilig B, Lampe M, Wiesmüller G, Richter C, Röther E, Rochel E, Gao I.
    Rheumatol Int; 2007 Aug 15; 27(10):975-9. PubMed ID: 17429636
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of leflunomide 100mg weekly compared to low dose methotrexate in patients with active rheumatoid arthritis. Double blind, randomized clinical trial.
    Jaimes-Hernández J, Meléndez-Mercado CI, Mendoza-Fuentes A, Aranda-Pereira P, Castañeda-Hernández G.
    Reumatol Clin; 2012 Aug 15; 8(5):243-9. PubMed ID: 22763150
    [Abstract] [Full Text] [Related]

  • 18. Long-term efficacy of leflunomide on disease activity and inhibition of joint damage: retrospective comparison with methotrexate for Japanese rheumatoid arthritis patients.
    Katayama K, Matsuno T.
    Mod Rheumatol; 2009 Aug 15; 19(5):513-21. PubMed ID: 19603251
    [Abstract] [Full Text] [Related]

  • 19. Tacrolimus in rheumatoid arthritis patients receiving concomitant methotrexate: a six-month, open-label study.
    Kremer JM, Habros JS, Kolba KS, Kaine JL, Borton MA, Mengle-Gaw LJ, Schwartz BD, Wisemandle W, Mekki QA, Tacrolimus-Methotrexate Rheumatoid Arthritis Study Group.
    Arthritis Rheum; 2003 Oct 15; 48(10):2763-8. PubMed ID: 14558080
    [Abstract] [Full Text] [Related]

  • 20. Clinical effectiveness and safety of additional administration of tacrolimus in rheumatoid arthritis patients with an inadequate response to abatacept: A retrospective cohort study.
    Suzuki M, Takahashi N, Kida D, Hirano Y, Kato T, Yabe Y, Oguchi T, Fujibayashi T, Hayashi M, Asai S, Ishiguro N, Kojima T.
    Int J Rheum Dis; 2019 Dec 15; 22(12):2199-2205. PubMed ID: 31647174
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.